Please Wait.....
Report
APAC Ovarian Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2022-11-01 I 145 Pages I Data Bridge Market Research
The Asia-Pacific ovarian cancer diagnostics market is projected to register a substantial CAGR of 6.3% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
Asia-Pacific Ovarian Cancer Diagnostics Market- By Product Type (Instruments, Kits and Reagents), Procedure Type (Biopsy Test, Medical Imaging Test, Blood Markers Testing, Genetic Testing), Cancer Type (Germ Cell, Epithelial Tumor, Stromal Cell Tumor), End User (Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of Asia-Pacific ovarian cancer diagnostics market are:
- Growing ovarian cancer awareness
- Improved diagnostic processes and techniques
- Increase in number of new cases every year
- Improved imaging techniques
Market Players:
The major companies which are dealing in the Asia-Pacific ovarian cancer diagnostics market are listed below:
- F. Hoffmann-la roche ltd
- Tosoh india pvt. Ltd.
- Luminex corporation
- Quest diagnostics incorporated
- Thermo fisher scientific Inc.
- Ngenebio
- Abbott
- Siemens healthcare private limited
- Myriad genetics Inc.
- Bio-rad laboratories, Inc.
- R&d systems, Inc.
- Inex innovate private limited
- Abcam plc.
- Monobind Inc.
- Fujirebio
- Mp biomedicals
- Biovision Inc.
- Boster biological technology
- Biogenix Inc. Pvt. Ltd.
- Genway biotech
- Lifespan biosciences, Inc
TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET 21
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 MULTIVARIATE MODELLING 31
2.7 PRODUCT TYPE LIFELINE CURVE 31
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.9 DBMR MARKET POSITION GRID 33
2.10 MARKET TESTING TYPE COVERAGE GRID 34
2.11 VENDOR SHARE ANALYSIS 35
2.12 SECONDARY SOURCES 36
2.13 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 40
4.1 PESTEL ANALYSIS 41
4.2 PORTER'S FIVE FORCES 42
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 43
5 INDUSTRY INSIGHTS 44
5.1 CONCLUSION 45
6 REGULATIONS OF THE ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET 46
7 MARKET OVERVIEW 48
7.1 DRIVERS 50
7.1.1 GROWING OVARIAN CANCER AWARENESS 50
7.1.2 IMPROVED DIAGNOSTIC PROCESSES AND TECHNIQUES 50
7.1.3 INCREASE IN NUMBER OF NEW CASES EVERY YEAR 51
7.1.4 IMPROVED IMAGING TECHNIQUES 51
7.2 RESTRAINS 52
7.2.1 HIGH COST OF DIAGNOSIS 52
7.2.2 ADVERSE EFFECTS OF THE TREATMENT 52
7.3 OPPORTUNITIES 53
7.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 53
7.3.2 GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS 53
7.4 CHALLENGES 54
7.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 54
7.4.2 LACK OF SKILLED PROFESSIONALS 55
8 ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 56
8.1 OVERVIEW 57
8.2 INSTRUMENTS 60
8.3 KITS AND REAGENTS 61
9 ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET, BY PROCEDURE TYPE 62
9.1 OVERVIEW 63
9.2 BLOOD MARKERS TESTING 66
9.3 MEDICAL IMAGING TEST 67
9.4 BIOPSY TEST 68
9.5 GENETIC TESTING 69
10 ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 70
10.1 OVERVIEW 71
10.2 EPITHELIAL TUMOR 74
10.3 GERM CELL 74
10.4 STROMAL CELL TUMOR 75
11 ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET, BY END USER 76
11.1 OVERVIEW 77
11.2 CANCER DIAGNOSTIC CENTERS 80
11.3 HOSPITAL LABORATORIES 80
11.4 RESEARCH INSTITUTES 81
11.5 OTHERS 82
12 ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY 83
12.1 ASIA-PACIFIC 84
12.1.1 JAPAN 90
12.1.2 CHINA 91
12.1.3 SOUTH KOREA 92
12.1.4 INDIA 93
12.1.5 AUSTRALIA 94
12.1.6 SINGAPORE 95
12.1.7 THAILAND 96
12.1.8 MALAYSIA 97
12.1.9 INDONESIA 98
12.1.10 PHILIPPINES 99
12.1.11 REST OF ASIA-PACIFIC 100
13 ASIA PACIFIC OVARIAN CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 101
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 101
14 SWOT ANALYSIS 102
15 COMPANY PROFILE 103
15.1 F. HOFFMANN-LA ROCHE LTD 103
15.1.1 COMPANY SNAPSHOT 103
15.1.2 REVENUE ANALYSIS 104
15.1.3 COMPANY SHARE ANALYSIS 104
15.1.4 PRODUCT PORTFOLIO 104
15.1.5 RECENT DEVELOPMENTS 105
15.2 TOSOH INDIA PVT. LTD. 106
15.2.1 COMPANY SNAPSHOT 106
15.2.2 COMPANY SHARE ANALYSIS 106
15.2.3 PRODUCT PORTFOLIO 107
15.2.4 RECENT DEVELOPMENT 107
15.3 LUMINEX CORPORATION (2022) 108
15.3.1 COMPANY SNAPSHOT 108
15.3.2 COMPANY SHARE ANALYSIS 108
15.3.3 PRODUCT PORTFOLIO 109
15.3.4 RECENT DEVELOPMENT 109
15.4 QUEST DIAGNOSTICS INCORPORATED (2022) 110
15.4.1 COMPANY SNAPSHOT 110
15.4.2 REVENUE ANALYSIS 110
15.4.3 COMPANY SHARE ANALYSIS 111
15.4.4 PRODUCT PORTFOLIO 111
15.4.5 RECENT DEVELOPMENTS 112
15.5 THERMO FISHER SCIENTIFIC INC 113
15.5.1 COMPANY SNAPSHOT 113
15.5.2 REVENUE ANALYSIS 113
15.5.3 COMPANY SHARE ANALYSIS 114
15.5.4 PRODUCT PORTFOLIO 114
15.5.5 RECENT DEVELOPMENT 114
15.6 ABBOTT 115
15.6.1 COMPANY SNAPSHOT 115
15.6.2 REVENUE ANALYSIS 116
15.6.3 PRODUCT PORTFOLIO 116
15.6.4 RECENT DEVELOPMENT 116
15.7 ABCAM PLC (2022) 117
15.7.1 COMPANY SNAPSHOT 117
15.7.2 REVENUE ANALYSIS 118
15.7.3 PRODUCT PORTFOLIO 118
15.7.4 1.7.4 RECENT DEVELOPMENT 118
15.8 BIOSUPPLY LTD 119
15.8.1 COMPANY SNAPSHOT 119
15.8.2 PRODUCT PORTFOLIO 119
15.8.3 RECENT DEVELOPMENT 119
15.9 BIO-RADBIO LABORATORIES 120
15.9.1 COMPANY SNAPSHOT 120
15.9.2 REVENUE ANALYSIS 121
15.9.3 PRODUCT PORTFOLIO 121
15.9.4 RECENT DEVELOPMENTS 122
15.10 BIOVISION INC. 123
15.10.1 COMPANY SNAPSHOT 123
15.10.2 PRODUCT PORTFOLIO 123
15.10.3 RECENT DEVELOPMENT 123
15.11 BIOGENIX INC. PVT. LTD. 124
15.11.1 COMPANY SNAPSHOT 124
15.11.2 PRODUCT PORTFOLIO 124
15.11.3 RECENT DEVELOPMENT 124
15.12 BOSTER BIOLOGICAL TECHNOLOGY 125
15.12.1 COMPANY SNAPSHOT 125
15.12.2 PRODUCT PORTFOLIO 125
15.12.3 RECENT DEVELOPMENT 125
15.13 FOUNDATION MEDICINE 126
15.13.1 COMPANY SNAPSHOT 126
15.13.2 PRODUCT PORTFOLIO 126
15.13.3 RECENT DEVELOPMENT 126
15.14 FUJIREBIO 127
15.14.1 COMPANY SNAPSHOT 127
15.14.2 PRODUCT PORTFOLIO 127
15.14.3 RECENT DEVELOPMENT 127
15.15 GENWAY BIOTECH 128
15.15.1 COMPANY SNAPSHOT 128
15.15.2 PRODUCT PORTFOLIO 128
15.15.3 RECENT DEVELOPMENT 128
15.16 INEX INNOVATIVE PRIVATE LIMITED 129
15.16.1 COMPANY SNAPSHOT 129
15.16.2 PRODUCT PORTFOLIO 129
15.16.3 RECENT DEVELOPMENT 129
15.17 LCM GENETIC SRL 130
15.17.1 COMPANY SNAPSHOT 130
15.17.2 PRODUCT PORTFOLIO 130
15.17.3 RECENT DEVELOPMENT 130
15.18 LIFESPAN BIOSCIENCES, INC 131
15.18.1 COMPANY SNAPSHOT 131
15.18.2 PRODUCT PORTFOLIO 131
15.18.3 RECENT DEVELOPMENTS 132
15.19 MP BIOMEDICALS 133
15.19.1 COMPANY SNAPSHOT 133
15.19.2 PRODUCT PORTFOLIO 133
15.19.3 RECENT DEVELOPMENT 133
15.20 MONOBIND INC. 134
15.20.1 COMPANY SNAPSHOT 134
15.20.2 PRODUCT PORTFOLIO 134
15.20.3 RECENT DEVELOPMENT 134
15.21 MYRIAD GENETICS, INC. 135
15.21.1 COMPANY SNAPSHOT 135
15.21.2 REVENUE ANALYSIS 135
15.21.3 PRODUCT PORTFOLIO 136
15.21.4 RECENT DEVELOPMENT 136
15.22 NGENEBIO 137
15.22.1 COMPANY SNAPSHOT 137
15.22.2 PRODUCT PORTFOLIO 137
15.22.3 RECENT DEVELOPMENTS 138
15.23 R&D SYSTEMS, INC. 139
15.23.1 COMPANY SNAPSHOT 139
15.23.2 PRODUCT PORTFOLIO 139
15.23.3 RECENT DEVELOPMENT 139
15.24 SIEMENS MEDICAL SOLUTIONS 140
15.24.1 COMPANY SNAPSHOT 140
15.24.2 REVENUE ANALYSIS 140
15.24.3 PRODUCT PORTFOLIO 141
15.24.4 RECENT DEVELOPMENT 141
16 QUESTIONNAIRE 142
17 RELATED REPORTS 145
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security